Lindell K Weaver1. 1. Hyperbaric Medicine, LDS Hospital, Salt Lake City, UT, USA. lindell.weaver@imail.org
Abstract
OBJECTIVE: To review aspects of hyperbaric medicine pertinent to treating critically ill patients with hyperbaric oxygen in both monoplace and multiplace chambers. DATA SOURCES: Literature review of online databases, research repositories, and clinical trial registries. RESULTS: The search of these resources produced information regarding technical considerations, feasibility, risk, and patient management. Hyperbaric oxygen is used in treating a number of disorders that occur in critically ill patients, including acute carbon monoxide poisoning, arterial gas embolism, severe decompression sickness, clostridial gas gangrene, necrotizing fasciitis, and acute crush injury. Most chambers in the United States treat outpatients with problem nonhealing wounds, and many chambers are not hospital-based. Only a few hyperbaric medicine centers have intensive care unit-level staffing, specialized equipment, a 24/7 schedule, and experience in treating critically ill patients. Not all intensive care unit-related equipment can be subjected to hyperbaric pressurization, and some equipment may increase the risk for fire inside the chamber. CONCLUSIONS: Treating critically ill patients with hyperbaric oxygen requires specialized equipment and personnel with intensive care unit skills and knowledge of the physiology and risks unique to hyperbaric oxygen exposure. Like with all medical interventions, it is important to consider the risk vs. the benefit of hyperbaric oxygen for any given critical care disorder, but hyperbaric oxygen can be delivered safely to critically ill patients. Many critical care environments without present hyperbaric oxygen capability may wish to consider offering hyperbaric oxygen to patients with hyperbaric oxygen-approved indications.
OBJECTIVE: To review aspects of hyperbaric medicine pertinent to treating critically illpatients with hyperbaric oxygen in both monoplace and multiplace chambers. DATA SOURCES: Literature review of online databases, research repositories, and clinical trial registries. RESULTS: The search of these resources produced information regarding technical considerations, feasibility, risk, and patient management. Hyperbaric oxygen is used in treating a number of disorders that occur in critically illpatients, including acute carbon monoxidepoisoning, arterial gas embolism, severe decompression sickness, clostridial gas gangrene, necrotizing fasciitis, and acute crush injury. Most chambers in the United States treat outpatients with problem nonhealing wounds, and many chambers are not hospital-based. Only a few hyperbaric medicine centers have intensive care unit-level staffing, specialized equipment, a 24/7 schedule, and experience in treating critically illpatients. Not all intensive care unit-related equipment can be subjected to hyperbaric pressurization, and some equipment may increase the risk for fire inside the chamber. CONCLUSIONS: Treating critically illpatients with hyperbaric oxygen requires specialized equipment and personnel with intensive care unit skills and knowledge of the physiology and risks unique to hyperbaric oxygen exposure. Like with all medical interventions, it is important to consider the risk vs. the benefit of hyperbaric oxygen for any given critical care disorder, but hyperbaric oxygen can be delivered safely to critically illpatients. Many critical care environments without present hyperbaric oxygen capability may wish to consider offering hyperbaric oxygen to patients with hyperbaric oxygen-approved indications.
Authors: Chai R Soh; Ricardo Pietrobon; John J Freiberger; Sophia T Chew; Dimple Rajgor; Mihir Gandhi; Jatin Shah; Richard E Moon Journal: Intensive Care Med Date: 2012-04-20 Impact factor: 17.440
Authors: Jean-Claude Lefebvre; Aissam Lyazidi; Miguel Parceiro; Giuseppe F Sferrazza Papa; Evangelia Akoumianaki; Deborah Pugin; Didier Tassaux; Laurent Brochard; Jean-Christophe M Richard Journal: Intensive Care Med Date: 2012-05-17 Impact factor: 17.440
Authors: Jason J Rose; Mehdi Nouraie; Marc C Gauthier; Anthony F Pizon; Melissa I Saul; Michael P Donahoe; Mark T Gladwin Journal: Crit Care Med Date: 2018-07 Impact factor: 7.598
Authors: Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio Journal: Am J Physiol Regul Integr Comp Physiol Date: 2019-05-15 Impact factor: 3.619
Authors: Luca Zazzeron; Chen Liu; Walfre Franco; Akito Nakagawa; William A Farinelli; Donald B Bloch; R Rox Anderson; Warren M Zapol Journal: Am J Respir Crit Care Med Date: 2015-11-15 Impact factor: 21.405